SECOND SIGHT MEDICAL PRODUCTS |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.97 USD | +0.01% |
|
+14.53% | -13.59% |
| 2022 | Vivani Medical Starts Nasdaq Trading Lower | MT |
| 2022 | Second Sight Medical Products, Inc.(NasdaqCM:EYES) dropped from NASDAQ Composite Index | CI |
Presentation Operator MessageOperator (Operator)Greetings and welcome to the Second Sight Seco...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Second Sight Medical Products, Inc. is engaged in developing, manufacturing and marketing implantable visual prosthetics devices that restore vision to blind individuals. The Company manufactures neuromodulation devices for blindness and engaged in developing new technologies to treat sight-impaired individuals. Its approved product, the Argus II Retinal Prosthesis System (Argus II), treats outer retinal degenerations, such as retinitis pigmentosa (RP). It is engaged in developing the Orion Visual Cortical Prosthesis System (Orion), an implanted cortical stimulation device, which provides artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease and eye injury. Orion works by converting video images captured by a miniature camera housed in a user's glasses into a series of small electrical pulses that are transmitted wirelessly to an array of electrodes.
Sector
-
- Stock Market
- Equities
- EYES Stock
- News Second Sight Medical Products
- Transcript : Second Sight Medical Products, Inc., Q2 2019 Earnings Call, Aug 06, 2019